Arcutis Biotherapeutics Inc.

01/12/2025 | Press release | Distributed by Public on 01/12/2025 07:30

Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.